Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva-Luise Hobl

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Thrombosis and Haemostasis|December 5, 2017
Tecarfarin: A Novel Vitamin K AntagonistEva-Luise Hobl, Bernd Jilma
Thrombosis and Haemostasis|May 1, 2015
Towards the development of specific antidotes: Idarucizumab for reversal of dabigatran effectsEva-Luise Hobl, Bernd Jilma
Biomedical Chromatography : BMC|November 24, 2012
Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by isocratic high-pressure liquid chromatography with post-column hydrolysis and fluorescence detectionEva-Luise Hobl, Bernd Jilma, Josef Ebner, et al.
British Journal of Clinical Pharmacology|July 18, 2017
Ticagrelor mitigates ischaemia-reperfusion induced vascular endothelial dysfunction in healthy young males - a randomized, single-blinded studyStefan Weisshaar, Brigitte Litschauer, Matthias Eipeldauer, et al.
European Journal of Clinical Investigation|November 18, 2014
Absorption kinetics of low-dose chewable aspirin--implications for acute coronary syndromesEva-Luise Hobl, Rainer W Schmid, Thomas Stimpfl, et al.
European Journal of Clinical Investigation|October 12, 2013
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelorEva-Luise Hobl, Ulla Derhaschnig, Christa Firbas, et al.
Cytometry. Part B, Clinical Cytometry|September 17, 2013
Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein phosphorylation to assess P2Y12 -inhibition after ticagrelor intakeEva-Luise Hobl, Bernd Jilma, Ulla Derhaschnig, et al.
Cytometry. Part B, Clinical Cytometry|July 31, 2013
Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y<sub>12</sub> -inhibition after ticagrelor intakeEva-Luise Hobl, Bernd Jilma, Ulla Derhaschnig, et al.
Frontiers in Physiology|July 12, 2021
Pharmacokinetic Modeling of Morphine's Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy VolunteersKatarzyna Buszko, Krystian Kubica, Eva-Luise Hobl, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2018
Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy VolunteersJohann Bartko, Christian Schoergenhofer, Michael Schwameis, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Thrombosis and Haemostasis|December 5, 2017
Tecarfarin: A Novel Vitamin K AntagonistEva-Luise Hobl, Bernd Jilma
Thrombosis and Haemostasis|May 1, 2015
Towards the development of specific antidotes: Idarucizumab for reversal of dabigatran effectsEva-Luise Hobl, Bernd Jilma
Biomedical Chromatography : BMC|November 24, 2012
Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by isocratic high-pressure liquid chromatography with post-column hydrolysis and fluorescence detectionEva-Luise Hobl, Bernd Jilma, Josef Ebner, et al.
British Journal of Clinical Pharmacology|July 18, 2017
Ticagrelor mitigates ischaemia-reperfusion induced vascular endothelial dysfunction in healthy young males - a randomized, single-blinded studyStefan Weisshaar, Brigitte Litschauer, Matthias Eipeldauer, et al.
European Journal of Clinical Investigation|November 18, 2014
Absorption kinetics of low-dose chewable aspirin--implications for acute coronary syndromesEva-Luise Hobl, Rainer W Schmid, Thomas Stimpfl, et al.
European Journal of Clinical Investigation|October 12, 2013
Reversal strategy in antagonizing the P2Y12 -inhibitor ticagrelorEva-Luise Hobl, Ulla Derhaschnig, Christa Firbas, et al.
Cytometry. Part B, Clinical Cytometry|September 17, 2013
Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein phosphorylation to assess P2Y12 -inhibition after ticagrelor intakeEva-Luise Hobl, Bernd Jilma, Ulla Derhaschnig, et al.
Cytometry. Part B, Clinical Cytometry|July 31, 2013
Comparison of a new ELISA-based with the flow cytometric assay for vasodilator-associated stimulated phosphoprotein (VASP) phosphorylation to assess P2Y<sub>12</sub> -inhibition after ticagrelor intakeEva-Luise Hobl, Bernd Jilma, Ulla Derhaschnig, et al.
Frontiers in Physiology|July 12, 2021
Pharmacokinetic Modeling of Morphine's Effect on Plasma Concentrations of Ticagrelor and Its Metabolite in Healthy VolunteersKatarzyna Buszko, Krystian Kubica, Eva-Luise Hobl, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2018
Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy VolunteersJohann Bartko, Christian Schoergenhofer, Michael Schwameis, et al.
Pageof 3